throbber
NUCLEIC ACIDS COMPONENTS AND THEIR ANALOGUES,LI.*
`
`SYNTHESIS OF 1-GLYCOSYL DERIVATIVES OF 5-AZAURACIL
`AND 5-AZACYTOSINE
`
`Institute of Organic Chemistry and Biochemistry, Czechoslovak Academy of Sciences, Prague
`
`A. PisKALA and F. Sorm
`
`Received January 2nd, 1964
`
`For the preparation of 1-glycosyl derivatives of 5-azauracil and 5-aza-
`cytosine a method is described starting from peracetylglycosyl isocyanates.
`Addition of 2-methylisourea affords 1-peracetylglycosyl-4-methylisobiurets
`which are condensed with ethyl orthoformate to form 1-peracetylglycosyl-4-
`methoxy-2-oxo-1 ,2-dihydro-1,3,5-triazines. Deacetylation and demethylation
`of the latter compoundsaffords 1-glycosyl-5-azauracils whereas deacetylation
`followed by amination yields 1-glycosyl-S-azacytosines. By this procedure,
`glucopyranosyl, ribopyranosyl and ribofuranosyl derivatives of 5-azauracil
`as well as of 5-azacytosine have been prepared.
`
`In the course of biochemical studies about cultivation of Escherichia coli in the
`presence of a subbacteriostatic concentration of 5-azauracil (2,4-dioxo-1,2,3,4-tetra-
`hydro-1,3,5-triazine),
`ribosylbiuret
`forming by decomposition of the unstable
`ribosyl-5-azauracil has been found in the medium. A detailed study of 5-azauracil
`anabolites has shown that cleavage of ribosyl-5-azauracil to ribosylbiuret proceeds
`in the culture of E. coli via N-formylribosylbiuret’, i.e., analogously to the cleavage
`of 5-azauracil to biuret?. Moreover, it has been demonstrated with the use of a cell-
`free extract of E. coli that 5-azauracil is a suitable substrate for microbial phospho-
`rylases as well as pyrophosphorylases which makespossible the synthesis of ribosyl-5-
`azauracil and ribosyl-5-azauracil 5’-phosphate*, resp. We have expected that ribosyl
`derivatives of 5-azauracil or 5-azacytosine (4-amino-2-oxo-1,2-dihydro-l,3,5-tri-
`azine) could exhibit marked biological effects similar to those of the corresponding
`6-azaanalogues.In fact, preliminary experiments seem to support this assumption*~ ’.
`In this paper, we have studied the possibility of a chemical preparation of 1-glyco-
`syl derivatives of 5-azauracil and 5-azacytosine which would represent the hitherto
`undescribed analogues of the appropriate pyrimidine nucleosides. Our attention
`has been focussed on the glucopyranosyl, ribopyranosyl and ribofuranosyl deriva-
`tives. The ribosyl derivatives were proposed for correlation with the above products
`of enzymic reactions.
`
`* Part L.: This Journal 29, 1736 (1964).
`
`2060
`
`Collection Czechoslov. Chem. Commun.
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0001
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0001
`
`

`

`Nucleic Acids Components and their Analogues. LI.
`
`In a recent paper®, we have described a general method for the preparation of
`1-substituted 5-azauracils as well as 5-azacytosines which consists in the condensation
`of isobiurets with orthoesters followed by treatment with hydrogen chloride or am-
`monia. Since this method represents, according to our experience, the most suitable
`procedure for the preparation of this type of compounds, we have tried to synthesize
`also the required glycosyl derivatives in this manner. We have started from tetra-
`acetylglucopyranosyl isocyanate which was prepared by Fischer? in a 22° yield on
`treatment of 1-bromo-2,3,4,6-tetra-O-acetyl-o-p-glucopyranose(I) with silver cyanate.
`Later on, Johnson and Bergmann'® described formation of a second, lower-melting
`modification. In several experiments, we isolated merely the higher-melting form.
`Furthermore, we were able to increase the yield (70%) by a suitable arrangement
`of the reaction conditions. Treatment with ammonia results in a product? to which the
`structure of 1-B-p-glucopyranosylurea was ascribed'!1”. Consequently, the product
`of the treatment with silver cyanate may be considered as 2,3,4,6-tetra-O-acetyl-B-
`D-glucopyranosyl isocyanate(II).
`Addition of 2-methylisourea afforded a high yield of a chromatographically homo-
`geneous amorphous product analyzing in agreement with the expected 1-(2,3,4,6-
`
`Table I
`
`Ultraviolet Spectra
`
`Compounds
`
`Solvent
`
`1,4-Dimethylisobiuret
`Til
`xX
`XVI
`1-Methyl-4-methoxy-2-oxo-1,2-
`dihydro-1,3,5-triazine
`Iv
`XT
`XVIT
`1-Methyl-5-azauracil
`Vv"
`XG?
`1-Methyl-5-azacytosine
`vi‘
`XI"
`XXII?
`
`96% ethanol
`96% ethanol
`96% ethanol
`96% ethanol
`
`acetonitril
`acetonitril
`acetonitril
`acetonitril
`96% ethanol
`96% ethanol
`96% ethanol
`water, pH 5-0
`water, pH 5-0
`water, pH 5-0
`water, pH 5-0
`
`
`
`
`
`Armax
`my
`
`i
`
`Zag
`221
`221
`221
`
`254
`254
`253
`253
`245
`240
`240
`247
`243
`243
`246
`
`loge
`
`4-18
`4-26
`4:28
`4:27
`
`3:34
`3:40
`3:39
`3°36
`3°20
`3°25
`3:24
`3°74
`3°81
`3-80
`3-78
`
`“ Spectra of the 5-azauracil and 5-azacytosine glycosyl derivatives were measured immediately
`after dissolution because of the time-dependenceoftheir extinction coefficient’?>.
`
`Vol. 29 (1964)
`
`2061
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0002
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0002
`
`

`

`Piskala, Sorm:
`
`tetra-O-acetyl-B-p-glucopyranosyl)-4-methylisobiuret (JIJ). Its ultraviolet spectrum
`is practically identical with that of the analogous 1,4-dimethylisobiuret (see Table I).
`The above product was condensed at 135°C with ethyl orthoformate in the stream
`of dry nitrogen to yield crystalline 1-(2,3,4,6-tetra-O-acetyl-B-p-glucopyranosyl)-4-
`methoxy-2-oxo-1,2-dihydro-1,3,5-triazine (IV). Its structure was established on com-
`parison of the ultraviolet spectrum with that of the analogous 1-methyl-4-methoxy-2-
`oxo-1,2-dihydro-1,3,5-triazine (Table 1).
`
`OCH,
`
`sont
`ROCH,
`KEY oy
`
`
`
`Oo N=C=o
`‘
`OR
`
`OR
`
`AgNCO
`
`SY
`H,N N
`Ss
`No
`
`ROCH,
`|
`oy
`~~~ KOR
`
`
`
`Oo
`
`:
`
`OR
`
`NH
`
`~
`
`/
`
`il
`
`IT
`
`Oo
`
`A‘
`
`NHle
`
`hy
`
`HOCH,
`
`|___o
`|
`OH
`HO N
`
`4
`OH
`
`V
`
`NH,
`\
`N N
`)
`|
`la Nes
`|
`Kk
`HO pa
`
`HOCH,
`
`
`Oo
`
`OH
`
`OH
`
`OCH,
`\
`N WN
`lyno
`
`;
`
`ROCH,
`
`
`HC(OC2Hs)s
`
`OR
`RO \N—V
`|
`OR
`
`IV
`
`1. CH3ONa/CH30H
`(2. Dowex 50 W (H*)
`
`|
`
`__NHs/CH30H
`
`R =CH,CO
`
`VI
`
`2062
`
`Collection Czechosiov. Chem. Commun.
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0003
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0003
`
`

`

`Nucleic Acids Components and their Analogues. LI.
`
`Transformation of the glucoside IV into the required 1-f-p-glucopyranosyl-5-
`azauracil
`(_V) was accomplished with methanolic hydrogen chloride or Dowex
`50 W(H*) ion exchange resin in methanol or sodium methoxide followed by Dowex
`50 W (H*) resin. When crystallised from aqueous ethanol, the substances formed
`a solvate with ethanol and water. Water may be removed by heating in vacuo at
`130°C for 1 hour whereas removal of ethanol requires 10 hours at the same tem-
`perature. Its structure was verified on a comparison of the ultraviolet spectrum with
`that of the analogous 1-methyl-5-azauracil’*, and, furthermore, by an acidic hydro-
`lysis yielding 5-azauracil and glucose. Moreover, the formation of a stable adduct
`with ethanol in the case of the glucoside Vclosely resembles the behaviour of 1-methyl-
`5-azauracil!*. The structure of both these adducts will be discussed in detail in a sub-
`sequent paper of this Series!’.
`A short action of a methanolic solution of ammonia at room temperature on the
`glucoside IV afforded crystalline 1-B-p-glucopyranosyl-5-azacytosine (VI) in a good
`yield. Its structure was confirmed on comparison of the ultraviolet spectrum with
`that of the analogous 1-methyl-5-azacytosine (see Table I) and by acidic hydrolysis
`yielding 5-azacytosine and glucose. The prolonged action of the methanolic solution
`of ammonia led to a second product, namely, 1-B-p-glucopyranosyl-3-guanylurea
`(VII). This compoundis obviously formed by cleavage of the triazine ting of the
`glucosyl derivative VI.
`
`6
`NON
`Sh
`CHO
`
`CH,
`XXI
`
`oO
`
`NH,
`|
`: =O
`
`NH
`
`—O
`
`|
`NH
`
`HOCH,
`
`os,
`oo
`—
`
`HO OH
`XIX
`
`NH,
`_an
`
`NH
`
`|C
`
`=O
`
`|
`NH
`
`HOCH,
`
`
`-—o,,
`Kon
`Ho N/V
`OH
`wa
`
`The above procedure was used also for the synthesis of 5-azauracil and 5-azacyto-
`sine ribopyranosyl derivatives. The starting 1-chloro-2,3,4-tri-O-acetyl-B-D-ribopyra-
`nose (VIII) wasreacted with silver cyanate undersimilar conditionsasin the preceding
`case. 2,3,4-Tri-O-acetyl-B-p-ribopyranosyl isocyanate (1X) was obtained as amorphous
`solid but its analysis as well as infrared spectrum, v(.N=C=O), 2252 cm~’, closely
`resembling that of peracetylglucosyl isocyanate IT, (WN=C=O), 2253 cm™~*, both
`speak in favour of the supposedstructure. Since in the reactions of halogenoses with
`silver cyanate the same steric course can be assumed as in the reactions with the
`
`Vol. 29 (1964)
`
`2063
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0004
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0004
`
`

`

`Piskala, Sorm:
`
`silver or mercury salts of pyrimidine and purine bases, we haveused the rule of Baker!®
`for allotment of the configuration at the glycosidic centre of the molecule. Treatment
`of the isocyanate 1X with 2-methylisourea afforded a high yield of crystalline 1-(2,3,4-
`tri-O-acetyl-B-p-ribopyranosyl)-4-methylisobiuret
`(X)
`the structure of which was
`confirmed by the ultraviolet spectrum (see Table I). Condensation of this compound
`with ethyl orthoformate at 135°C resulted in crystalline 1-(2,3,4-tri-O-acetyl-B-p-
`ribopyranosyl)-4-methoxy-2-oxo-1,2-dihydro-1,3,5-triazine (XJ) the ultraviolet spec-
`trum of which corresponded to the proposed structure (Table 1).
`Successive treatment of the ribosyl derivative XJ with sodium methoxide and
`Dowex 50 W (H*) ion exchange resin yielded a product to which the structure of
`
`OCH,
`
`X
`H,N N
`
`|o
`
`N
`
`Oo
`
`ads
`
`—o Cc
`\|
`RO 7
`
`,
`
`OR OR
`
`Aenco
`
`0 N=C-0
`%‘
`RO +—/
`
`OR OR
`
`oe
`
`vu
`
`1x
`
`|—o 3"
`
`RO \—/
`
`OR OR
`
`x
`
`O |
`
`N NH
`lL
`N’\o
`
`1, CH3ONa/CH30H_,
`(2. Dowex 50 W (H*)
`
`/\
`
`e
`
`\
`
`HO ty
`\
`OH OH
`XI
`
`‘NH,
`A
`i
`N’No
`:
`%
`/\
`K
`nd NY
`
`——O
`
`OH OH
`XI
`
`NH3/CH30H =
`
`R = COCH,
`
`OCH,
`>
`¥ \
`{| )
`Bo
`
`S\
`
`io
`HC(OC2Hs)s K
`_
`-—
`
`XI
`
`2064
`
`Collection Czechoslov. Chem. Commun.
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0005
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0005
`
`

`

`Nucleie Acids Components and their Analogues. LI.
`
`1-B-p-ribopyranosyl-S-azauracil (XII) was ascribed on the basis of the ultraviolet
`spectrum (see Table I). This compound wascleaved by the action of hydrochloric
`acid with the formation of ribose and 5-azauracil, and, furthermore, formed a sol-
`vate with ethanol.
`Treatment of the compound XJ with a methanolic solution of ammonia afforded
`the expected 1-B-p-ribopyranosyl-5-azacytosine (XIII) as crystals. The proposed
`structure was again confirmed bythe ultraviolet spectrum (Table I) and acidic hydro-
`lysis yielding ribose and 5-azacytosine.
`Finally, the above method was applied also for the preparation of 5-azauracil
`and 5-azacytosine ribofuranosyl derivatives. The reaction of 1-chloro-2,3,5-tri-O-
`acetyl-p-ribofuranose (XIV) with silver cyanate was performed under similar con-
`ditions as in the preceding examples. 2,3,5-Tri-O-acetyl-B-p-ribofuranosyl isocyanate
`(XV) was obtained as sirup and was characterised by the infrared spectrum,
`v(N=C=O), 2252 cm~'. The B-configurationat the glycosidic centre of the molecule
`was ascribed on the basis of Baker’s rule'®. The proof of validity of this assumption
`follows also from the structure of ribofuranosyl-5-azauracil (XX) (vide infra).
`Treatment of the isocyanate XVwith 2-methylisourea afforded crystalline 1-(2,3,5-tri-
`O-acetyl-B-p-ribofuranosyl)-4-methylisobiuret (XVI) the spectrum of which wassimi-
`lar to spectra of the preceding isobiurets (Table I). Condensation of this product
`with ethyl orthoformate at 135°C resulted in glassy 1-(2,3,5-tri-O-acetyl-B-p-ribofura-
`nosyl)-4-methoxy-2-oxo-1,2-dihydro-1,3,5-triazine (XVII) possessing the expected
`ultraviolet spectrum (Table 1).
`Deacetylation and demethylation of the ribofuranosyl derivative XVII was ex-
`pected, in analogy to the treatment of the compounds IV and XI, to yield 1-B-p-
`ribofuranosyl-5-azauracil (5-azauridine; XVIII). The reaction was again performed
`by the successive treatment with sodium methoxide and Dowex 50 W(H*) ion
`exchange resin. A crystalline product was obtained the elementary analysis of which
`corresponded to 5-azauridine. The substance, however, did not form any adduct
`with ethanol (in contrast to the analogous products V and XJJ) and, in a neutral
`medium, did not exhibit any maximum in the near ultraviolet region. At pH 5-0, the
`expected maximum(J,,,, 241 mp) was registered but the molar extinction coefficient
`was considerably lower(log ¢ 2-68) in comparison with other 1-substituted 5-azaura-
`cils. Moreover, the absorption disappeared rather quickly (no maximumcould be
`registered after one hour). The infrared spectrum (in dimethyl sulfoxide) showed
`a broad band at approx. 1535 cm™! (the triazine ring) and two carbonyl maxima
`at 1670 and 1715cm7?. No maximum at 1630 cm! (characteristic for the azo-
`methine linkage**) could be found (also in nujol suspension). Oxidation with potas-
`sium periodate at pH 7:0 and room temperature consumed 1:5 mole of periodic
`acid per 1 mole of the ribosyl derivative in the course of 24 hours as determined
`polarographically!7” (the theory requires 1 mole of periodic acid). The higher value
`is obviously due to a subsequent oxidation. During the paper electrophoresis in
`a borate buffer (pH 7-0) the substance migrated to the anodesimilar to uridine. The
`
`Vol. 29 (1904)
`
`2065
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0006
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0006
`
`

`

`Piskala, Sorm:
`
`substance wasreadily cleaved with hydrochloric acid even at room temperature with
`the formation of ribose and 5-azauracil, and with dilute aqueous ammonia afforded
`1-B-p-ribofuranosylbiuret (XIX). Spectral data showed that in neutral
`solutions.
`and in the solid state the substance possessed no double bond in the position 5,6 of
`the azauracil moiety. This fact can be explained by the addition of a hydroxylic
`function to the azomethine linkage. Principally, any of the three hydroxylic functions
`in positions 2’, 3’ or 5’ can be involved intra- or intermolecularly. The possibility
`of a intermolecular addition can be precluded on the basis of the fact that both
`glucopyranosyl derivative V and ribopyranosyl derivative XII of 5-azauracil do not
`undergo such a reaction. Results of the oxidation with potassium periodate and the
`
`OCH,
`
`\
`
`ROCH,
`
`0
`
`Sshycl
`
`RO Ae
`
`AgNco
`
`ROCH,
`
`=o
`
`N=C=O
`
`0
`
`y
`
`OR OR
`
`ROCH,
`
`H,N i
`No
`
`HN
`
`c“
`
`on Co
`
`XIV
`
`XV
`
`XVI
`
`O |
`
`rh "
`H,oA
`
`_1.CHsONa/CH30H__
`2. Dowex 50 W (H*)
`
`nha
`|
`“x
`N WN
`
`|
`IL
`~ N“No
`»|
`OR to
`
`XVI
`
`HC(OC2Hs)3
`
`LCi
`XX
`IsN N
`l he
`
`HOCH,
`
`N No
`
`NH,
`
`NH3/CH30H
`
`OH OH
`
`XXII
`
`2066
`
`Collection Czechoslov. Chem. Commun.
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0007
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0007
`
`

`

`Nucleic Acids Components and their Analogues. LI.
`
`electrophoretic behaviour are in agreement with a free cis-diol arrangement on the
`carbon atoms 2’ and 3’. The intramolecular addition to the azomethine linkageis,
`therefore, accomplished with the primary alcoholic function and the substance may
`be formulated as 5’,6-anhydro-6-hydroxy-5,6-dihydro-5-azauridine (XX). Theinfra-
`red spectrum of the substanceis similar to that of the related 1,3,5-trimethyl-6-meth-
`oxy-2,4-dioxohexahydro-1,3,5-triazine’® (XXI) measured in dimethyl
`sulfoxide
`(a broad band at 1520, 1680 and 1720 cm~*); this fact is a further support of the
`proposed structure.
`The spontaneous intramolecular addition of the primary hydroxylic function to the
`azomethine linkage represents simultaneously a proof of the B-configuration on the
`glycosidic centre of the molecule. Since glucosyl-5-azauracil V which also possesses.
`a free primary alcoholic function does not nudergothis reaction, it may be assumed
`that the addition will be probably limited to furanosyl derivatives with B-configura-
`tion and a free hydroxylic function in the position 5’.
`Both 5’,6-anhydro-6-hydroxy-5,6-dihydro-5-azauridine (XX) and ribosylbiuret
`XIX were identical with products forming in the medium in the course of cultivation
`of E. coli in the presence of 5-azauracil’. The identification was carried out by means.
`of paper chromatography.
`
`From the ultraviolet spectrum of the ribosyl derivative XX in a weakly acidic medium it could
`be assumed that the compoundis partly transformed into 5-azauridine (XVIII) and that some
`equilibrium exists depending on the pH of the solution. This problem will be discussed in full
`detail elsewhere! >.
`
`——eae
`
`O
`
`N
`/
`HN NH
`Hs)
`
`H,C——O”“N’\y
`a,
`=
`
`OH OH
`
`oO
`
`HOCH,
`
`|
`N NH
`a
`NNXo
`O%.
`IN{
`
`OH OH
`
`XX
`
`XVII
`
`Treatment of the ribofurancsyl derivative XVII with a methanolic solution of
`ammoniaaffordedreadily crystalline 1-B-p-ribofuranosyl-5-azacytosine (5-azacytidine
`XXII). Structure of this compound was confirmed on comparison of ultraviolet
`(see Table I) and infrared (Fig. 1) spectra with those of the analogous 1-methyl-5-
`azacytosine. By means of hydrochloric acid, the product was cleaved into ribose
`and 5-azacytosine.
`In summaryit may be noted that the S-azaanalogues of pyrimidine nucleosides differ
`in their properties very markedly from the pyrimidine as well as 6-azapyrimidine
`nucleosides, especially by the ease of cleavage of the N-glycosidic bond by the action
`
`Vol. 29
`
`(1964)
`
`2067
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0008
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0008
`
`

`

`Piskala, Sorm:
`
`of mineral acids and by theinstability of the triazine moiety in alkaline media. As
`quite exceptional may be regarded also the behaviour of the 5-azauracil ribofuranosyl
`derivative where an intramolecular addition of the primary alcoholic function occurs
`to the azomethine linkage.
`
`1
`
`2
`
`0
`
`%(T)
`
`50
`
`100
`0
`
`50
`
`100
`
`1500
`
`cm:!
`
`1700
`
`Fig. 1
`Infrared Spectra of 1-Methyl-5-azacytosine (1) and 5-Azacytidine (2)
`(Measured in Nujol Suspension)
`
`Experimental
`
`Melting points were determined on aheated microscope stage and are corrected. Unless otherwise stated, the analytical
`samples were dried at 0-3 mm Hg and room temperature for ten hours, Paper chromatography was performed on paper
`Whatman No | by the descending technique (without previous saturations) in solvent systems (S;) 1-butanol—acetic
`acid—water (4: 1: 1) and (S2) 1-butanol-ethanol-water (40: 11: 19), Detection was carried out by viewing in ultraviolet
`light or according to Reindel and Hoppe!®. Thevicina }cis-diol arrangement ofthe ribosy! derivatives was detected with
`potassium periodate and benzidine?°.
`
`2,3,4,6-Tetra-O-acetyl-8-p-glucopyranosyl isocyanate (//)
`
`a«-Acetobromoglucose (4:11 g; 0-01 mole) was heated in dry xylene (20 ml) with thoroughly
`dried silver cyanate?! (4-5 g; 0-03 mole) under efficient stirring and with exclusion of atmospheric
`moisture. The bath temperature was gradually increased to 100°C in the course of 30 minutes
`and the mixture was kept at this temperature for further 30 minutes. Additional two portions of
`silver cyanate (1-5 g; 0-01 mole) were then addedin intervals of 30 minutes, the mixture was heated
`for 30 minutes, filtered off while still hot and the precipitate washed twice with 10-ml portions
`of hot xylene. The combinedfiltrates were cooled and precipitated with light petroleum (40 ml).
`
`2068
`
`Collection Czechoslov. Chem. Commun.
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0009
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0009
`
`

`

`Nucleic Acids Components and their Analogues. LI.
`
`The supernatant was decanted (the residual precipitate was discarded), treated with additional
`20 ml of light petroleum anda little active charcoal and the mixture was quickly filtered through
`a French filter. The clear filtrate deposited almost instantaneously the crystalline isocyanate.
`The next day, the product wascollected, yield 2-3 g; m.p. 119—120°C (literature records'® m.p.
`120°C and 125°C (see”). Concentration of the mother liquors followed by crystallisation from the
`ethyl acetate—-light petroleum solvent mixture afforded additional 0-37 g of the product. Total
`yield 2-55 g (70%). Infrared spectrum (chloroform): »(N—C—O), 2253 cm.
`
`1-(2,3,4,6-Tetra-O-acetyl-8- p-glucopyranosyl)-4-methylisobiuret (IJ)
`
`A stirred soiution of 2,3,4,6-tetra-O-acetyl-6-p-glucopyranosyl isocyanate (3-73 g; 0-01 mole)
`in dry chloroform (50 ml) was slowly treated at —15°C under exclusion of atmospheric moisture
`with a solution of freshly prepared 2-methylisourea?? (0-7 g; 9-5 millimoles) in chloroform (10 ml).
`The resulting solution was allowed to stand at room temperature for one hour and the chloroform
`was evaporated under diminished pressure (bath temperature 30°C). The residual sirup was dis-
`solved in benzene (10 ml) and the solution treated with light petroleum (50 ml). The supernatant
`was decanted and discarded. The glassy residue was dissolved in hot benzene (10 ml), the solution
`allowed to cool and treated with light petroleum (50 ml). The resulting solid precipitate was
`repeatedly triturated underlight petroleum and decanted. Yield 4-01 g (94%, based on 2-methyl-
`isourea), m.p.90—100°C. Attempts to crystallise this product from various solvents failed. The
`Rr value 0°84 (the solvent system S,), detected according to Reindel and Hoppe?!®. The ultra-
`violet spectrum is given in Table I. For C,7H,5N30,, (447:3) calculated: 45-65% C, 5-64% H,
`9-39°% N; found: 45-48% C, 5-889 H, 906% N.
`
`1-(2,3,4,6-Tetra-O-acetyl-8-p-glucopyranosyl)-4-methoxy-2-oxo-1 ,2-dihydro-1,3,5-triazine
`(TV)
`
`A solution of the isobiuret derivative I/I (4-47 g; 0-01 mole) in ethyl orthoformate (40 ml)
`was heated (bath temperature, 135°C) in distillation apparatus in a stream of pure dry nitrogen
`under exclusion of atmospheric moisture (potassium hydroxide tube) for eight hours. After
`five hours of heating, the crystalline condensation product began to deposit and clog the nitrogen
`inlet tube. For the remaining period of heating nitrogen was introduced to the surface of the
`mixture. After standing at —15°C overnight, the crystals were collected and washed with a small
`amount of ether. Yield 2-28 g (50%); m. p. 235—237°C. The melting point did not change on
`recrystallisation of the product from absolute ethanol. The ultraviolet spectrum is shown in
`Table I. For C,gH,3N30,, (457-3) calculated: 47-27% C, 507% H, 9-19% N; found: 47-40% C,
`5-09 H, 9:12% N.
`
`1-8-p-Glucopyranosyl-5-azauracil (V)
`
`A suspension of the methoxytriazine JV (4°57 g; 0-01 mole) in absolute methanol (300 ml)
`was allowed to stand at room temperature in a stoppered vessel with 50 ml of 0-5N sodium
`methoxide in methanol for 30 minutes. The resulting solution was treated with moist Dowex
`50 W (H*) ion exchangeresin (100 g) previously washed with water and methanol. The mixture
`was kept at room temperature under occasionalstirring for two hours, filtered off and the resin
`washed thoroughly with methanol. The combinedfiltrates were evaporated under diminished pres-
`sure (bath temperature 30°C) and the glassy residue was dissolved without any heating in 1000 ml
`of the ethanol. The resulting solution was concentrated under diminished pressure (bath tem-
`perature 30°C) to a small volume (30 ml). A solid was deposited in the course of the evaporation.
`The mixture was allowed to stand for three days at room temperature and for one day at +3°C.
`The crystalline product was collected and washed with a small amount of ethanol. Yield 2-41 g
`
`Vol 29 (1964)
`
`2069
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0010
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0010
`
`

`

`Piskala, Sorm:
`
`(71%) of a chromatographically homogeneous product; the detection was performed by viewing
`in ultraviolet light and according to Reindel and Hoppe!® (treatment of the paper with chlorine
`was prolonged for 30 minutes); the Ry value 0-11 (the solvent system S,) and 0-08 (the solvent
`system S,). The substance melted at 175—180°C (softening from 165°C). The analysis showed
`that glucosyl-5-azauracil V was solvated with ethanol and water. For C,H,3;N3,07-C,H,O.H,O
`(339-3) calculated: 38-94% C, 6-24% H, 12-3994 N; found: 39-05% C, 620% H, 12-65% N. —
`When dried over P,O; for
`1 hour at 130°C/0-05mm Hg,
`the substance loses the water.
`For CyH,3N3;07.C,H,O (321-3) calculated: 41-12% C, 5-96% H, 13-08% N; found: 41-30% C,
`5:94% H, 13-28% N. Ethanol was removed by drying over phosphorus pentoxide at 130°C/0-:05mm
`Hg for ten hours. For CgH,3;N307 (275-2) calculated: 39-27% C, 4-76% H, 15-27% N; found:
`38-94% C, 501% H, 15-03% N. The substance is sparingly soluble in ethanol and readily soluble
`in water. The recrystallisation was performed by dissolving the substance in a minimum amount
`water without any heating, addition of a tenfold volume of ethanol, inocculation and standing at
`+3°C overnight. The substance separated in the form of colorless fine needles solvated with
`ethanol and water; m.p. 183—185°C. The ultraviolet spectrum is shown in Table I.
`
`The preparation of glucosyl-5-azauracil V from the methoxytriazine J V was accomplished also
`by the action of moist Dowex 50 W (H*) ion exchangeresin for 4 hours (without the previous
`removalof the protecting acetyl groups with sodium methoxide) or by treatment with an 1% solution
`of dry hydrogen chloride in absolute methanol for 4 hours (the hydrogen chloride was removed
`with silver carbonate). In both these procedures, the yield was lower than in the preparation
`described in the preceding paragraph. The action of methanolic hydrogen chloride was accompa-
`nied by the formation of 5-azauracil (Rp value 0-31) as shown by paper chromatography in the
`solvent system S,.
`
`Hydrolysis. Glucosyl-5-azauracil V (275 mg; 1 millimole) was heated in a steam bath with 1 ml
`of 6N-HCI for five minutes. The mixture was evaporated under diminished pressure, the residue
`was treated with ethanol (10 ml) and evaporated again. The residue was refluxed shortly with
`ethanol (2 ml) and the solution allowed to stand at +3°C overnight. The crystalline solvate of
`5-azauracil with ethanol was collected and washed with ethanol. Drying over phosphorus pento-
`xide at 130°C/0-05 mm Hgfor ten hours afforded 92 mg (81%) of S-azauracil, m.p. 284—285°C
`(decomposition; sealed capillary) undepressed on admixture’ with an authentic specimen. The
`identification was further performed by comparison of the ultraviolet spectra (4,,,, 237 mu,
`log e 3-5) and by paper chromatography. In the mother liquors, glucose was detected by means
`of paper chromatography. The cleavage with hydrochloric acid was found to proceed even at
`room temperature, though very slowly.
`
`1-8-p-Glucopyranosyl-5-azacytosine (VJ)
`
`The methoxytriazine JV (4:57 g; 0-01 mole) was kept at room temperature for 90 minutes
`in a sealed tube with 50 ml of absolute methanol previously saturated at 0°C with dry ammonia
`gas. The mixture was shaken occasionally. In the course of 40 minutes, a clear solution was
`obtained. The solution was concentrated under diminished pressure (bath temperature 25°C)
`to a small volume (the amorphous product partly separated). The residue was triturated with
`absolute ether (300 ml) and the resulting powder was repeatedly decanted with additional crops
`of absolute ether (three 100-ml portions). The amorphous product was then collected, washed with
`ether and triturated with 80 mlabs. methanol. Thesubstance gradually dissolved and separated
`again in the form of crystals. The mixture was allowed to stand at room temperature overnight
`and thenfiltered off. The product was washed with methanol and dried under diminished pressure.
`Yield 1-65 g (60°) of glucosyl-5-azacytosine VJ, m.p. 258—260°C (decomposition). The ultra-
`violet spectrum is shown in Table I. The substance was chromatographically homogeneous and
`was detected in ultraviolet light or according to Reindel and Hoppe’?; the Ry values 0-07 (the
`
`2070
`
`Collection Czechoslov. Chem. Commun.
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0011
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0011
`
`

`

`Nucleic Acids Components and their Analogues. LI.
`
`solvent system S,) and 0-05 (the solvent system S.). The recrystallisation was performed by dis-
`solving in a minimum amount of water (without heating), addition of a tenfold volume of metha-
`nol, inocculation and standing at +3°C overnight. The recrystallised substance melted at 260 to
`262°C (decomposition). For CgH,4N4O,¢ (274-2) calculated: 39-42% C, 5-15% H, 20-43% N;
`found: 39-33% C, 5-19% H, 20-15% N.
`1 millimole) was heated in a steam bath with
`Hydrolysis. Glucosy]-5-azacytosine VJ (274 mg;
`1 ml of 6N-HCI for five minutes. The mixture was allowed to cool, diluted with acetone (2 ml) and
`kept at room temperature overnight. The crystalline material was collected, washed with acetone
`a dried under diminished pressure to give 104 mg (70%) of 5-azacytosine hydrochloride. The
`identification was performed by comparison of the ultraviolet spectra (in 4n-HCI, 4,,,, 250 my,
`log ¢ 2:95) and by paper chromatography. The cleavage proceeds readily even at room temperature.
`Glucose was detected in the mother liquors.
`
`1-8-p-Glucopyranosyl-3-guanylurea (VIJ)
`
`The methoxytriazine JV (0-457 g; 1 mmole) was kept at room temperature with 5 ml of metha-
`nolic ammonia for 48 hours (cf. the preceding preparation). The solution was evaporated under
`diminished pressure (bath temperature 30°C), the residue was dissolved in methanol (50 ml)
`andthe resulting solution evaporated again. The residue was triturated with methanol (4 ml) and
`allowed to stand overnight. The obtained crystals were collected, washed with methanol and dried
`under diminished pressure to give 0:12 g (41%) of the solvate of glucosylguanylurea VII with
`methanol as indicated by analysis; m.p. 201—203°C (decomposition). For CgH,6N40,-CH,O
`(296-2) calculated: 36-49% C, 6-81% H, 18-92% N; found: 36-33% C, 6-60% H, 18-94% N. The
`recrystallisation was performed by dissolving the substance in a minimum amount of water and
`treating the solution with a tenfold volume of hot ethanol. The resulting crystals melted at
`207—209°C (decomposition) and represented the hydrate of glucosylguanylurea VJJ. For
`CgH,6N4O0,-H,0O (282-2) calculated: 34-03% C, 6-42% H, 19-85% N; found: 34-04% C, 6-13% H,
`20-00% N. The solvated water was removed on heating over phosphorus pentoxide at 100°C/0-05
`mm Hgfor 8 hours. For CgH,;,N40, (264-2) calculated: 36-36% C, 6:11% H, 21:20% N; found:
`36-48% C, 6:35%4 H, 20-90% N. The substance exhibited no absorption in the near ultraviolet
`region. The paper chromatograms were detected according to Reindel and Hoppe??. The R--
`values; 0-14 (the solvent system S,) and 0-11 (the solvent system S,). Some glucosyl-5-azacytosine
`VI was detected in the mother liquors by means of paper chromatography.
`
`2,3,4-Tri-O-acetyl--p-ribopyranosyl isocyanate (LY)
`
`Dry hydrogen chloride was introduced with cooling and under exclusion of atmospheric
`moisture into a suspension of finely ground 1,2,3,4-tetra-O-acetyl-8-p-ribopyranose (6:36 g; 0-02
`mole) in absolute ether (100 ml) and acetyl chloride (1 ml) for two hours. The stoppered flask was
`allowed to stand at +3°C for five days. The solution was evaporated under diminished pressure
`(bath temperature 20°C) to the consistence of a thick sirup. The residual hydrogen chloride and
`acetic acid were removed by repeated codistillations (i vacuo) with five 40-ml portions of dry
`toluene (bath temperature 30°C). The colorless sirup was diluted with absolute ether (10 ml) to
`deposit immediately the crystalline 1-chloro-2,3,4-tri-O-acetyl-@-p-ribopyranosyl chloride (VII).
`The mixture was allowed to stand at — 15°C overnight,filtered off, the product washed with a small
`amountof absolute ether and dried in a desiccator over potassium hydroxide. Yield 4-9 g (83%);
`m.p. 93—95°C (theliterature records”? m.p. 95°C).
`The above halogenose VIII (2:95 g; 0-01 mole) was heated with the thoroughly dried silver
`cyanate? (4-5 g; 0-03 mole) in 20 ml of dry xylene under similar conditions as in the case of glu-
`cosyl isocyanate JJ. When the reaction was finished, the silver salts were removed byfiltration
`and washed with two 10-ml portions of hot xylene. The combined filtrates were cooled and
`
`Vol. 29 (1964)
`
`2071
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0012
`
`Apotex v. Cellgene - IPR2023-00512
`Petitioner Apotex Exhibit 1024-0012
`
`

`

`Piskala, Sorm:
`
`precipitated with dry light petroleum (80 ml). The mixture was allowed to stand in a stoppered
`vessel at +3°C overnight. The clear colorless supernatant was decanted (the residual glassy
`precipitate was discarded) and evaporated under diminished pressure (bath temperature

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket